Comparative efficacy of Mometasone Furoate versus Fluticasone Fumarate Nasal Spray Using Clinical and Radiological Scoring in Children with Adenoid Hypertrophy
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 60
- 试验地点
- 1
- 主要终点
- Identification of the most effective intranasal corticosteroid for improving symptoms and reducing adenoid size in children with adenoid hypertrophy.
研究概览
简要总结
60 Children 2- 14 years of age will be enrolled in the study with consent from the parents.
Randomization followed by symptomatology scoring and radiological scoring will be done.
30 children are allocated in group A - will receiving MOMETASONE FUROATE
Other 30 children are allocated in group B - will receiving FLUTICASONE FUMARATE
Regular follow for adherence, compliance and complication will be done
Repeat symptomatology scoring and radiological scoring will be done after 3 months and results will be compared
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 盲法
- None
入排标准
- 年龄范围
- 2.00 Year(s) 至 14.00 Year(s)（—）
- 性别
- All
入选标准
- •Children aged between 2 and 14 years who are newly diagnosed with adenoid hypertrophy, exhibiting symptoms such as snoring, mouth-breathing and obstructive breathing during sleep, and confirmed by lateral neck radiography, will be included in the study.
排除标准
- •Immunocompromised patients, nasal structural disease, prior tonsil or adenoid surgery, craniofacial abnormalities.
结局指标
主要结局
Identification of the most effective intranasal corticosteroid for improving symptoms and reducing adenoid size in children with adenoid hypertrophy.
时间窗: 3 months
Insights into the optimal choice of intranasal corticosteroid based on clinical and radiological considerations.
时间窗: 3 months
次要结局
未报告次要终点
研究者
VANDANAPU VENKATA SIR HARSHA
SRM MEDICAL COLLEGE HOSPITAL AND RESEARCH CENTER